Article Details

AstraZeneca boosts heart and kidney business with US$1.8-billion CinCor Pharma deal

Retrieved on: 2023-01-10 09:31:41

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca boosts heart and kidney business with US$1.8-billion CinCor Pharma deal. View article details on hiswai:

Excerpt

A sign outside AstraZeneca's North America headquarters, in Wilmington, Del., on March 22, 2021.Rachel Wisniewski/Reuters.

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up